Is activated clotting time measurement time important after heparin anticoagulation during cardiac surgery?

Basit Öğe Kaydı
dc.authorscopusid7006498929
dc.authorscopusid6602393555
dc.authorscopusid7004591561
dc.authorscopusid20434616300
dc.authorscopusid8560325700
dc.authorscopusid6701467427
dc.contributor.authorÇolak A.
dc.contributor.authorArar C.
dc.contributor.authorEge T.
dc.contributor.authorSevdi S.
dc.contributor.authorTuran N.
dc.contributor.authorPamukçu Z.
dc.date.accessioned2024-06-12T10:29:07Z
dc.date.available2024-06-12T10:29:07Z
dc.date.issued2007
dc.description.abstractIn our study, we aimed to investigate the sufficiency of 2 and 5 min. waiting time that is required for activated clotting time measurement after anticoagulation with heparine for cardiopulmonary by-pass in the patients undergoing coronary artery surgery. 50 patients undergoing elective cardiopulmonary bypass (CPB) were included to the study. Standard premedication, monitorization, anesthesia induction and maintenance were applied to all patients. 300 U kg-1 heparin was applied before left internal mammarian artery clamping during the surgical procedure. After heparin application ACT values that were measured in 2 and 5th min. were compared. In conclusion, we found that in order to control ACT value, there is no statistical difference between taking blood 2 min. after and taking blood 5 min. after heparin application. Especially in cases that required urgent aortic cannulation and induction of cardiopulmonary by-pass, 2 minutes waiting time for ACT is safe as well as 5 minutes waiting time.en_US
dc.identifier.endpage34en_US
dc.identifier.issn1305-5550
dc.identifier.issue1en_US
dc.identifier.scopus2-s2.0-34548201741en_US
dc.identifier.scopusqualityN/Aen_US
dc.identifier.startpage31en_US
dc.identifier.urihttps://hdl.handle.net/20.500.14551/17559
dc.identifier.volume13en_US
dc.indekslendigikaynakScopusen_US
dc.language.isotren_US
dc.relation.ispartofGogus-Kalp-Damar Anestezi ve Yogun Bakim Dernegi Dergisien_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectActivated Clotting Time; Cardiopulmonary Bypass Pump; Coronary Artery Bypass Grafting Surgery; Heparinen_US
dc.subjectDiapam; Diazepam; Fentanyl Citrate; Heparin; Lidocaine; Liquemine; Pancuronium Bromide; Sevoflurane; Unclassified Drug; Adult; Aged; Anesthesia Induction; Anticoagulation; Artery Catheterization; Artery Clamp; Article; Blood Clotting Time; Cardiopulmonary Bypass; Clinical Article; Clinical Trial; Controlled Clinical Trial; Controlled Study; Coronary Artery Surgery; Elective Surgery; Female; Human; Male; Patient Safety; Premedication; Randomized Controlled Trial; Statistical Significanceen_US
dc.titleIs activated clotting time measurement time important after heparin anticoagulation during cardiac surgery?en_US
dc.title.alternativeKardiyak cerrahi sirasinda heparin antikoagülasyonu sonrasi aktive edilmiş pihtilaşma zamani ölçümü için zaman önemli mi?en_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu